HAE PEER ANALYSIS

Haemonetics Corporation — metric-by-metric comparison with peers and the industry median

HAEHaemonetics Corporation

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

HAEIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	HAE	COH	4DX	PHIA	SHL	SN	Ind. Median
P/E	35.57	24.11	—	24.62	18.92●	20.83	27.09
P/B	4.35	4.30	-77.13●	2.10	2.18	2.51	2.51
EV/EBITDA	15.85	15.11	—	10.81	12.04	9.98●	15.39
P/S	2.59	3.53	252.89	1.35●	1.72	2.11	2.62

Financial Health
Metric	HAE	COH	4DX	PHIA	SHL	SN	Ind. Median
Current Ratio	2.95	2.46	6.57●	1.32	1.10	2.57	3.28
Debt/Equity	153.8%	22.1%	-22.6%●	71.1%	84.1%	62.9%	44.7%
NetDebt/EBITDA	3.49	0.42●	0.71	2.03	3.04	1.72	0.82

Profitability
Metric	HAE	COH	4DX	PHIA	SHL	SN	Ind. Median
Net Margin	7.3%	14.6%●	-3,684.6%	5.5%	9.1%	10.1%	-5.7%
ROE	12.0%	18.1%●	—	8.4%	11.4%	12.1%	-8.6%
ROA	4.0%	12.4%●	-264.3%	3.6%	4.6%	6.1%	-6.4%
EBITDA Margin	21.0%	24.0%	-818.8%	15.4%	19.1%	25.6%●	5.2%

Growth + Dividend
Metric	HAE	COH	4DX	PHIA	SHL	SN	Ind. Median
Rev. Growth	-2.0%	2.0%●	-26.0%	-1.9%	-0.3%	—	7.4%
NI Growth	-42.0%	-6.8%	—	160.1%●	0.3%	—	16.7%
Div. Yield	—	3.6%●	—	3.5%	2.9%	3.5%	1.1%
Payout	—	81.5%	—	33.8%	48.4%	52.8%	39.0%

Valuation
Metric	HAE	ITGR	IRTC	LIVN	TMDX	AXGN	Ind. Median
P/E	35.57	22.32	—	43.61	14.97●	—	27.09
P/B	4.35	1.86●	25.22	3.86	5.21	9.39	2.51
EV/EBITDA	15.85	13.64●	337.09	20.71	21.29	—	15.39
P/S	2.59	1.71●	5.16	3.26	4.05	9.66	2.62

Financial Health
Metric	HAE	ITGR	IRTC	LIVN	TMDX	AXGN	Ind. Median
Current Ratio	2.95	3.75	5.17	1.33	6.74	7.10●	3.28
Debt/Equity	153.8%	81.4%	452.4%	27.6%	174.8%	8.4%●	44.7%
NetDebt/EBITDA	3.49	4.13	14.26	-0.95●	2.87	7.53	0.82

Profitability
Metric	HAE	ITGR	IRTC	LIVN	TMDX	AXGN	Ind. Median
Net Margin	7.3%	7.7%	-3.5%	7.5%	27.0%●	-13.2%	-5.7%
ROE	12.0%	8.6%	-22.4%	9.5%	45.2%●	-18.0%	-8.6%
ROA	4.0%	4.2%	-2.9%	4.2%	15.1%●	-13.0%	-6.4%
EBITDA Margin	21.0%	18.0%	1.6%	15.0%	22.0%●	-3.5%	5.2%

Growth + Dividend
Metric	HAE	ITGR	IRTC	LIVN	TMDX	AXGN	Ind. Median
Rev. Growth	-2.0%	6.0%	27.4%	12.4%	30.2%●	22.4%	7.4%
NI Growth	-42.0%	84.5%	—	—	251.2%●	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on HAE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.